Salmonella enterica Serovar Typhi: Antimicrobial drug resistance in Asia and the molecular mechanism of reduced susceptibility to the fluoroquinolones.


Chau, TT; Campbell, JI; Galindo, CM; Van Minh Hoang, N; Diep, TS; Nga, TT; Van Vinh Chau, N; Tuan, PQ; Page, AL; Ochiai, RL; Schultsz, C; Wain, J; Bhutta, ZA; Parry, CM; Bhattacharya, SK; Dutta, S; Agtini, M; Dong, B; Honghui, Y; Anh, DD; Canh, DG; Naheed, A; Albert, MJ; Phetsouvanh, R; Newton, PN; Basnyat, B; Arjyal, A; La, TT; Rang, NN; Phuong, LT; Van Be Bay, P; von Seidlein, L; Dougan, G; Clemens, JD; Vinh, H; Hien, TT; Chinh, NT; Acosta, CJ; Farrar, J; Dolecek, C; (2007) Salmonella enterica Serovar Typhi: Antimicrobial drug resistance in Asia and the molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrobial agents and chemotherapy, 51 (12). pp. 4315-23. ISSN 0066-4804 DOI: 10.1128/AAC.00294-07

Full text not available from this repository.

Abstract

This study describes the pattern and extent of drug resistance in 1,774 strains of Salmonella enterica serovar Typhi isolated across Asia between 1993 and 2005 and characterizes the molecular mechanisms underlying the reduced susceptibilities to fluoroquinolones of these strains. For 1,393 serovar Typhi strains collected in southern Vietnam, the proportion of multidrug resistance has remained high since 1993 (50% in 2004) and there was a dramatic increase in nalidixic acid resistance between 1993 (4%) and 2005 (97%). In a cross-sectional sample of 381 serovar Typhi strains from 8 Asian countries, Bangladesh, China, India, Indonesia, Laos, Nepal, Pakistan, and central Vietnam, collected in 2002 to 2004, various rates of multidrug resistance (16 to 37%) and nalidixic acid resistance (5 to 51%) were found. The eight Asian countries involved in this study are home to approximately 80% of the world's typhoid fever cases. These results document the scale of drug resistance across Asia. The Ser83-->Phe substitution in GyrA was the predominant alteration in serovar Typhi strains from Vietnam (117/127 isolates; 92.1%). No mutations in gyrB, parC, or parE were detected in 55 of these strains. In vitro time-kill experiments showed a reduction in the efficacy of ofloxacin against strains harboring a single-amino-acid substitution at codon 83 or 87 of GyrA; this effect was more marked against a strain with a double substitution. The 8-methoxy fluoroquinolone gatifloxacin showed rapid killing of serovar Typhi harboring both the single- and double-amino-acid substitutions.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Faculty of Infectious and Tropical Diseases > Dept of Pathogen Molecular Biology
PubMed ID: 17908946
URI: http://researchonline.lshtm.ac.uk/id/eprint/8875

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
479Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item